Meldon Kahan

2.5k total citations
95 papers, 1.7k citations indexed

About

Meldon Kahan is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and General Health Professions. According to data from OpenAlex, Meldon Kahan has authored 95 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Public Health, Environmental and Occupational Health, 41 papers in Epidemiology and 28 papers in General Health Professions. Recurrent topics in Meldon Kahan's work include Opioid Use Disorder Treatment (46 papers), Substance Abuse Treatment and Outcomes (37 papers) and Prenatal Substance Exposure Effects (25 papers). Meldon Kahan is often cited by papers focused on Opioid Use Disorder Treatment (46 papers), Substance Abuse Treatment and Outcomes (37 papers) and Prenatal Substance Exposure Effects (25 papers). Meldon Kahan collaborates with scholars based in Canada, United States and United Kingdom. Meldon Kahan's co-authors include Anita Srivastava, Lynn Wilson, Alice Ordean, Angela Mailis, Deana Midmer, Sheryl Spithoff, Lisa Graves, Sue Ross, Pamela Leece and Suzanne Wong and has published in prestigious journals such as BMJ, Medical Care and Journal of Advanced Nursing.

In The Last Decade

Meldon Kahan

90 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meldon Kahan Canada 22 945 580 436 420 360 95 1.7k
Elizabeth M. Oliva United States 24 1.1k 1.2× 765 1.3× 232 0.5× 379 0.9× 466 1.3× 53 1.8k
Daniel P. Alford United States 27 1.8k 1.9× 1.1k 2.0× 512 1.2× 557 1.3× 686 1.9× 81 2.8k
Gráinne Cousins Ireland 22 812 0.9× 848 1.5× 271 0.6× 245 0.6× 185 0.5× 74 2.0k
Karl A. Sporer United States 26 830 0.9× 421 0.7× 285 0.7× 142 0.3× 256 0.7× 78 2.5k
Joanna L. Starrels United States 26 1.2k 1.3× 624 1.1× 466 1.1× 345 0.8× 580 1.6× 76 2.2k
Jennifer McNeely United States 27 1.0k 1.1× 1.2k 2.1× 277 0.6× 600 1.4× 99 0.3× 99 2.0k
Gerald Cochran United States 22 1.1k 1.2× 577 1.0× 323 0.7× 291 0.7× 315 0.9× 116 1.6k
Arthur Robin Williams United States 22 1.2k 1.2× 1.1k 1.8× 400 0.9× 296 0.7× 159 0.4× 70 2.0k
Judith I. Tsui United States 26 1.1k 1.2× 1.9k 3.2× 308 0.7× 266 0.6× 170 0.5× 147 2.7k
Jan L. Losby United States 14 1.7k 1.8× 478 0.8× 461 1.1× 176 0.4× 885 2.5× 35 2.1k

Countries citing papers authored by Meldon Kahan

Since Specialization
Citations

This map shows the geographic impact of Meldon Kahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meldon Kahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meldon Kahan more than expected).

Fields of papers citing papers by Meldon Kahan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meldon Kahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meldon Kahan. The network helps show where Meldon Kahan may publish in the future.

Co-authorship network of co-authors of Meldon Kahan

This figure shows the co-authorship network connecting the top 25 collaborators of Meldon Kahan. A scholar is included among the top collaborators of Meldon Kahan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meldon Kahan. Meldon Kahan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srivastava, Anita, et al.. (2025). Initiation of extended-release buprenorphine in emergency department patients: A retrospective cohort study. The American Journal of Emergency Medicine. 94. 71–75.
2.
Sloan, Matthew E., Christian S. Hendershot, Meldon Kahan, et al.. (2025). Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine. Journal of Addiction Medicine. 19(6). 708–715.
4.
Corace, Kim, Kednapa Thavorn, Kelly D. Suschinsky, et al.. (2023). Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use. JAMA Network Open. 6(11). e2344528–e2344528. 4 indexed citations
5.
Leece, Pamela, Daniel Z. Buchman, Michael A. Hamilton, et al.. (2020). Improving opioid guideline adherence: evaluation of a multifaceted, theory-informed pilot intervention for family physicians. BMJ Open. 10(1). e032167–e032167. 8 indexed citations
6.
Nelson, LaRon E., et al.. (2019). Effectiveness of opiate substitution treatment in reducing HIV risk behaviors among African, Caribbean and black people. JBI Evidence Synthesis. 18(3). 610–618. 2 indexed citations
7.
Kahan, Meldon, et al.. (2017). Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.. PubMed. 63(2). 137–145. 39 indexed citations
8.
Spithoff, Sheryl & Meldon Kahan. (2015). Changement de paradigme Transférer la prise en charge des troubles liés à l'usage d'alcool des soins spécialisés aux soins primaires. Canadian Family Physician. 61(6). 495–497. 2 indexed citations
9.
Ordean, Alice, et al.. (2015). Obstetrical and Neonatal Outcomes of Methadone-Maintained Pregnant Women: A Canadian Multisite Cohort Study. Journal of Obstetrics and Gynaecology Canada. 37(3). 252–257. 25 indexed citations
10.
Argoff, Charles E., Meldon Kahan, & Edward M. Sellers. (2014). Preventing and managing aberrant drug-related behavior in primary care: Systematic review of outcomes evidence. Journal of Opioid Management. 10(2). 119–134. 23 indexed citations
11.
Graves, Lisa, et al.. (2014). The management of opioid dependence during pregnancy in rural and remote settings. Canadian Medical Association Journal. 187(1). E41–E46. 12 indexed citations
12.
Campbell‐Scherer, Denise, Julia H. Rogers, Donna Manca, et al.. (2014). Guideline harmonization and implementation plan for the BETTER trial: Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Family Practice. CMAJ Open. 2(1). E1–E10. 19 indexed citations
13.
Ordean, Alice, et al.. (2013). Integrated care for pregnant women on methadone maintenance treatment. Canadian Family Physician. 59(10). 4 indexed citations
14.
Srivastava, Anita, et al.. (2012). Prescription opioid use and misuse. Canadian Family Physician. 58(4). 1 indexed citations
15.
Kahan, Meldon, et al.. (2011). Pharmacists' experiences with dispensing opioids. Canadian Family Physician. 57(11). 4 indexed citations
16.
Kahan, Meldon, Lynn Wilson, Angela Mailis, & Anita Srivastava. (2011). Lignes directrices canadiennes sur l’utilisation sécuritaire et efficace des opioïdes pour la douleur chronique non cancéreuse: Résumé clinique pour les médecins de famille. Partie 2: populations particulières. Canadian Family Physician. 57(11). 2 indexed citations
17.
Ordean, Alice & Meldon Kahan. (2011). Comprehensive treatment program for pregnant substance users in a family medicine clinic.. PubMed. 57(11). e430–5. 36 indexed citations
18.
Kahan, Meldon, et al.. (2009). Short-term outcomes in patients attending a primary care-based addiction shared care program.. PubMed. 55(11). 1108–1109.e5. 7 indexed citations
19.
Kahan, Meldon, et al.. (2004). Attitudes and knowledge of family medicine residents toward brief interventions for problem drinkers. Medical Education Online. 9. 18. 5 indexed citations
20.
Kahan, Meldon, et al.. (1985). Ambulatory care of the aged in Kupat Holim clinics.. PubMed. 21(3). 264–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026